BioMarin Pharmaceutical Inc. (VIE:BMRN)
Austria · Delayed Price · Currency is EUR 47.26
+0.49 (1.05%)
Last updated: Feb 2, 2026, 1:00 PM CET
BioMarin Pharmaceutical Market Cap
BioMarin Pharmaceutical has a market cap or net worth of €9.39 billion as of February 4, 2026. Its market cap has decreased by -17.63% in one year.
Market Cap
9.39B
Enterprise Value
8.65B
Revenue
2.64B
Ranking
n/a
PE Ratio
21.16
Stock Price
€47.26
Market Cap Chart
Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 425.62M to 9.39B, an increase of 2,105.24%. That is a compound annual growth rate of 12.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 9.37B | -3.65% |
| Dec 31, 2025 | 9.72B | -19.63% |
| Dec 31, 2024 | 12.10B | -26.36% |
| Dec 29, 2023 | 16.43B | -8.70% |
| Dec 30, 2022 | 18.00B | 26.18% |
| Dec 31, 2021 | 14.26B | 9.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OMV Aktiengesellschaft | 16.45B |
| Raiffeisen Bank International AG | 14.37B |
| BAWAG Group AG | 10.90B |
| Strabag SE | 10.42B |
| Vienna Insurance Group AG | 8.72B |
| Andritz AG | 7.31B |
| Voestalpine AG | 7.12B |
| Telekom Austria AG | 5.99B |